Corbus Pharmaceuticals Holdings, Inc. - PE Ratio

The PE Ratio as of September 2026 (TTM) for Corbus Pharmaceuticals Holdings, Inc. (0SZI.L) is -1.46

According to Corbus Pharmaceuticals Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.46. This represents a change of -5.65% compared to the average of -1.55 of the last 4 quarters.

Corbus Pharmaceuticals Holdings, Inc. (0SZI.L) Historical PE Ratio (quarterly & annually)

How has 0SZI.L PE Ratio performed in the past?

The mean historical PE Ratio of Corbus Pharmaceuticals Holdings, Inc. over the last ten years is -4.73. The current -1.46 PE Ratio has changed 2.99% with respect to the historical average. Over the past ten years (40 quarters), 0SZI.L's PE Ratio was at its highest in in the June 2019 quarter at 59.00. The PE Ratio was at its lowest in in the September 2021 quarter at -14.71.

Corbus Pharmaceuticals Holdings, Inc. (0SZI.L) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Corbus Pharmaceuticals Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Corbus Pharmaceuticals Holdings, Inc. (0SZI.L) Average PE Ratio

How has 0SZI.L PE Ratio performed in the past?

The current PE Ratio of Corbus Pharmaceuticals Holdings, Inc. (0SZI.L) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Corbus Pharmaceuticals Holdings, Inc. (0SZI.L) PE Ratio vs. Peers

How is 0SZI.L’s PE Ratio compared to its peers?

Corbus Pharmaceuticals Holdings, Inc.’s PE Ratio is greater than Insight Molecular Diagnostics Inc. (-2.70), less than Sangamo Therapeutics, Inc. (0), greater than Heron Therapeutics, Inc. (-1.78), less than Accuray Incorporated (-0.63), greater than Atara Biotherapeutics Inc (-8.40), less than Adicet Bio, Inc. (-0.83), greater than Abeona Therapeutics Inc. (-5.10), greater than Codexis, Inc. (-4.26), less than Kyntra Bio, Inc. (0.14), less than Q32 Bio Inc. (3.99),

Build a custom stock screener for Corbus Pharmaceuticals Holdings, Inc. (0SZI.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corbus Pharmaceuticals Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corbus Pharmaceuticals Holdings, Inc. (0SZI.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corbus Pharmaceuticals Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.